ZYM-AMLODIPINE DIN 02342804
Status: Cancelled Post Market
Holder: ZYMCAN PHARMACEUTICALS INC
Molecule: AMLODIPINE (AMLODIPINE BESYLATE)
Health Canada record
| Active ingredient(s) | AMLODIPINE (AMLODIPINE BESYLATE) 10.0 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C08CA01 AMLODIPINE |
| Original market date | 29-Apr-2010 |
| Current status date | 16-Jun-2014 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing AMLODIPINE (AMLODIPINE BESYLATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02326817 | AMLODIPINE | PRO DOC LIMITEE | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 10 MG | Marketed |
| 02326795 | AMLODIPINE | PRO DOC LIMITEE | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 2.5 MG | Marketed |
| 02326809 | AMLODIPINE | PRO DOC LIMITEE | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 5 MG | Marketed |
| 02331292 | AMLODIPINE | SANIS HEALTH INC | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 10 MG | Marketed |
| 02331284 | AMLODIPINE | SANIS HEALTH INC | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 5 MG | Marketed |
| 02273381 | APO-AMLODIPINE | APOTEX INC | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 10 MG | Marketed |
| 02273373 | APO-AMLODIPINE | APOTEX INC | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 5 MG | Marketed |
| 02273306 | CADUET | BGP PHARMA ULC | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 10 MG; ATORVASTATIN (ATORVASTATIN CALCIUM) 40 MG | Marketed |
| 02273314 | CADUET | BGP PHARMA ULC | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 10 MG; ATORVASTATIN (ATORVASTATIN CALCIUM) 80 MG | Marketed |
| 02273233 | CADUET | BGP PHARMA ULC | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 5 MG; ATORVASTATIN (ATORVASTATIN CALCIUM) 10 MG | Marketed |
| 02273241 | CADUET | BGP PHARMA ULC | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 5 MG; ATORVASTATIN (ATORVASTATIN CALCIUM) 20 MG | Marketed |
| 02273268 | CADUET | BGP PHARMA ULC | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 5 MG; ATORVASTATIN (ATORVASTATIN CALCIUM) 40 MG | Marketed |
| 02273276 | CADUET | BGP PHARMA ULC | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 5 MG; ATORVASTATIN (ATORVASTATIN CALCIUM) 80 MG | Marketed |
| 02273284 | CADUET | BGP PHARMA ULC | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 10 MG; ATORVASTATIN (ATORVASTATIN CALCIUM) 10 MG | Marketed |
| 02273292 | CADUET | BGP PHARMA ULC | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 10 MG; ATORVASTATIN (ATORVASTATIN CALCIUM) 20 MG | Marketed |
| 02272113 | MYLAN-AMLODIPINE | MYLAN PHARMACEUTICALS ULC | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 5.0 MG | Marketed |
| 02272121 | MYLAN-AMLODIPINE | MYLAN PHARMACEUTICALS ULC | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 10.0 MG | Marketed |
| 00878928 | NORVASC | BGP PHARMA ULC | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 5 MG | Marketed |
| 00878936 | NORVASC | BGP PHARMA ULC | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 10 MG | Marketed |
| 02284073 | PMS-AMLODIPINE | PHARMASCIENCE INC | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 10.0 MG | Marketed |
| 02284065 | PMS-AMLODIPINE | PHARMASCIENCE INC | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 5 MG | Marketed |
| 02295148 | PMS-AMLODIPINE | PHARMASCIENCE INC | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 2.5 MG | Marketed |
| 02331489 | RIVA-AMLODIPINE | LABORATOIRE RIVA INC. | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 2.5 MG | Marketed |
| 02331500 | RIVA-AMLODIPINE | LABORATOIRE RIVA INC. | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 10 MG | Marketed |
| 02331497 | RIVA-AMLODIPINE | LABORATOIRE RIVA INC. | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 5 MG | Marketed |
| 02284391 | SANDOZ AMLODIPINE | SANDOZ CANADA INCORPORATED | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 10 MG | Marketed |
| 02284383 | SANDOZ AMLODIPINE | SANDOZ CANADA INCORPORATED | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 5 MG | Marketed |
| 02330474 | SANDOZ AMLODIPINE | SANDOZ CANADA INCORPORATED | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 2.5 MG | Marketed |
| 02297485 | TEVA-AMLODIPINE | TEVA CANADA LIMITED | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 5 MG | Marketed |
| 02297493 | TEVA-AMLODIPINE | TEVA CANADA LIMITED | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 10 MG | Marketed |
| 02341093 | ACCEL-AMLODIPINE | ACCEL PHARMA INC | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 5 MG | Cancelled Post Market |
| 02341107 | ACCEL-AMLODIPINE | ACCEL PHARMA INC | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 10 MG | Cancelled Post Market |
| 02343193 | AMLODIPINE | MELIAPHARM INC | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 2.5 MG | Cancelled Post Market |
| 02343207 | AMLODIPINE | MELIAPHARM INC | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 5 MG | Cancelled Post Market |
| 02339382 | AMLODIPINE BESYLATE TABLETS, 10MG | DR. REDDY'S LABORATORIES INC | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 10 MG | Cancelled Pre Market |
| 02339374 | AMLODIPINE BESYLATE TABLETS, 5MG | DR. REDDY'S LABORATORIES INC | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 5 MG | Cancelled Pre Market |
| 02331942 | AMLODIPINE TABLETS | RANBAXY PHARMACEUTICALS CANADA INC. | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 10 MG | Cancelled Pre Market |
| 02331934 | AMLODIPINE TABLETS | RANBAXY PHARMACEUTICALS CANADA INC. | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 5 MG | Cancelled Pre Market |
| 02326841 | DOM-AMLODIPINE | DOMINION PHARMACAL | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 10 MG | Cancelled Post Market |
| 02326825 | DOM-AMLODIPINE | DOMINION PHARMACAL | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 2.5 MG | Cancelled Post Market |
| 02326833 | DOM-AMLODIPINE | DOMINION PHARMACAL | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 5 MG | Cancelled Post Market |
| 02280124 | GD-AMLODIPINE | GENMED A DIVISION OF PFIZER CANADA ULC | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 2.5 MG | Cancelled Post Market |
| 02280132 | GD-AMLODIPINE | GENMED A DIVISION OF PFIZER CANADA ULC | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 5 MG | Cancelled Post Market |
| 02280140 | GD-AMLODIPINE | GENMED A DIVISION OF PFIZER CANADA ULC | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 10 MG | Cancelled Post Market |
| 02331071 | JAMP-AMLODIPINE | JAMP PHARMA CORPORATION | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 5 MG | Cancelled Post Market |
| 02331098 | JAMP-AMLODIPINE | JAMP PHARMA CORPORATION | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 10 MG | Cancelled Post Market |
| 00878901 | NORVASC | UPJOHN CANADA ULC | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 2.5 MG | Cancelled Pre Market |
| 02326787 | PHL-AMLODIPINE | PHARMEL INC | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 10 MG | Cancelled Post Market |
| 02326779 | PHL-AMLODIPINE | PHARMEL INC | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 5 MG | Cancelled Post Market |
| 02326760 | PHL-AMLODIPINE | PHARMEL INC | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 2.5 MG | Cancelled Post Market |
| 02340186 | Q-AMLODIPINE | QD PHARMACEUTICALS ULC | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 10 MG | Cancelled Post Market |
| 02340178 | Q-AMLODIPINE | QD PHARMACEUTICALS ULC | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 5 MG | Cancelled Post Market |
| 02259613 | RATIO-AMLODIPINE TABLETS 10MG | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 10 MG | Cancelled Post Market |
| 02259605 | RATIO-AMLODIPINE TABLETS 5MG | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 5 MG | Cancelled Post Market |
| 02321858 | TARO-AMLODIPINE | SUN PHARMA CANADA INC | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 5 MG | Dormant |
| 02321866 | TARO-AMLODIPINE | SUN PHARMA CANADA INC | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 10 MG | Dormant |
| 02250500 | TEVA-AMLODIPINE | TEVA CANADA LIMITED | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 10 MG | Cancelled Post Market |
| 02297477 | TEVA-AMLODIPINE | TEVA CANADA LIMITED | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 2.5 MG | Dormant |
| 02250497 | TEVA-AMLODIPINE | TEVA CANADA LIMITED | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 5 MG | Cancelled Post Market |
| 02342790 | ZYM-AMLODIPINE | ZYMCAN PHARMACEUTICALS INC | Tablet | AMLODIPINE (AMLODIPINE BESYLATE) 5.0 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 11210 | 2010-03-31 | Abbreviated New Drug Submission (ANDS) | New manufacturer and product name |